Pre-order Enquiry
Request Free Sample
Global Inhalation Therapy Nebulizer Market Growth 2019-2024
SKU ID : LPI-13842974 | Publishing Date : 08-Feb-2019 | No. of pages : 163
A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler.
The global average price of Inhalation Therapy Nebulizer is in the decreasing trend, from 64.9 USD/Unit in 2012 to 61.0 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Inhalation Therapy Nebulizer includes Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers, and the proportion of Pneumatic Nebulizers in 2016 is about 56%.
Inhalation Therapy Nebulizer is widely used for the treatment of COPD, Cystic Fibrosis, Asthma and other respiratory disorders. The most proportion of Inhalation Therapy Nebulizer is used to treat Asthma, and the proportion in 2016 is 53%.
North America is the largest supplier of Inhalation Therapy Nebulizer, with a production market share nearly 29% in 2016. Japan is the second largest supplier of Inhalation Therapy Nebulizer Media, enjoying production market share nearly 22% in 2016.
North America is the largest consumption place, with a consumption market share nearly 39% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32%.
Market competition is not intense. PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
According to this study, over the next five years the Inhalation Therapy Nebulizer market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 1270 million by 2024, from US$ 870 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inhalation Therapy Nebulizer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Therapy Nebulizer market by product type, application, key manufacturers and key regions and countries.
This study considers the Inhalation Therapy Nebulizer value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
COPD
Cystic Fibrosis
Asthma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Trudell Medical International
GF Health Products
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Inhalation Therapy Nebulizer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Inhalation Therapy Nebulizer market by identifying its various subsegments.
Focuses on the key global Inhalation Therapy Nebulizer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inhalation Therapy Nebulizer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inhalation Therapy Nebulizer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The global average price of Inhalation Therapy Nebulizer is in the decreasing trend, from 64.9 USD/Unit in 2012 to 61.0 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Inhalation Therapy Nebulizer includes Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers, and the proportion of Pneumatic Nebulizers in 2016 is about 56%.
Inhalation Therapy Nebulizer is widely used for the treatment of COPD, Cystic Fibrosis, Asthma and other respiratory disorders. The most proportion of Inhalation Therapy Nebulizer is used to treat Asthma, and the proportion in 2016 is 53%.
North America is the largest supplier of Inhalation Therapy Nebulizer, with a production market share nearly 29% in 2016. Japan is the second largest supplier of Inhalation Therapy Nebulizer Media, enjoying production market share nearly 22% in 2016.
North America is the largest consumption place, with a consumption market share nearly 39% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32%.
Market competition is not intense. PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
According to this study, over the next five years the Inhalation Therapy Nebulizer market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 1270 million by 2024, from US$ 870 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inhalation Therapy Nebulizer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Therapy Nebulizer market by product type, application, key manufacturers and key regions and countries.
This study considers the Inhalation Therapy Nebulizer value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
COPD
Cystic Fibrosis
Asthma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
PARI GmbH
Omron
Drive DeVilbiss Healthcare
Philips Respironics
Yuwell
Leyi
Folee
Medel S.p.A
Briggs Healthcare
3A Health Care
Trudell Medical International
GF Health Products
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Inhalation Therapy Nebulizer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Inhalation Therapy Nebulizer market by identifying its various subsegments.
Focuses on the key global Inhalation Therapy Nebulizer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inhalation Therapy Nebulizer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inhalation Therapy Nebulizer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
